Diabetes and restenosis
Restenosis, defined as the re-narrowing of an arterial lumen after revascularization,
represents an increasingly important issue in clinical practice. Indeed, as the number of stent …
represents an increasingly important issue in clinical practice. Indeed, as the number of stent …
In stent neo-atherosclerosis: pathophysiology, clinical implications, prevention, and therapeutic approaches
A Nusca, MM Viscusi, F Piccirillo, A De Filippis… - Life, 2022 - mdpi.com
Despite the dramatic improvements of revascularization therapies occurring in the past
decades, a relevant percentage of patients treated with percutaneous coronary intervention …
decades, a relevant percentage of patients treated with percutaneous coronary intervention …
[HTML][HTML] Management of in-stent restenosis
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …
A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial
J Baan, BE Claessen, KB Dijk, J Vendrik… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The authors sought to evaluate the relative performance of a drug-eluting
balloon (DEB) and a drug-eluting stent (DES) in patients with any (bare-metal or drug …
balloon (DEB) and a drug-eluting stent (DES) in patients with any (bare-metal or drug …
Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management
A Abouelnour, T Gori - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Despite the introduction of drug-eluting stents to combat the neointimal hyperplasia that
occurred after BMS implantation, in-stent restenosis is still encountered in a significant …
occurred after BMS implantation, in-stent restenosis is still encountered in a significant …
[HTML][HTML] Association of non-insulin-dependent insulin resistance indices with lower limb artery restenosis after drug-coated balloon angioplasty
Z Qiao, Y Zhuang, Z Wang - Lipids in Health and Disease, 2024 - pmc.ncbi.nlm.nih.gov
Background This study aimed to investigate the associations between noninsulin-dependent
insulin resistance indices (NI-IRIs), including the triglyceride-glucose (TyG) index, TyG-BMI …
insulin resistance indices (NI-IRIs), including the triglyceride-glucose (TyG) index, TyG-BMI …
Comparison of drug-coated balloon angioplasty vs. drug-eluting stent implantation for drug-eluting stent restenosis in the routine clinical practice: a meta-analysis of …
Y Zhu, K Liu, X Kong, J Nan, A Gao, Y Liu… - Frontiers in …, 2021 - frontiersin.org
Introduction: In-stent restenosis (ISR) remains a challenging issue despite the great advance
of drug-eluting stents (DES). In addition, the consensus was lacking regarding the optimal …
of drug-eluting stents (DES). In addition, the consensus was lacking regarding the optimal …
[HTML][HTML] Linc-POU3F3 is overexpressed in in-stent restenosis patients and induces VSMC phenotypic transformation via POU3F3/miR-449a/KLF4 signaling pathway
J Zhang, F Gao, T Ni, W Lu, N Lin, C Zhang… - American Journal of …, 2019 - ncbi.nlm.nih.gov
Background: With the extensive application of stent implantation in patients undergoing
percutaneous coronary interventions (PCI), there are chances that in-stent restenosis (ISR) …
percutaneous coronary interventions (PCI), there are chances that in-stent restenosis (ISR) …
[HTML][HTML] Update on coronary artery bioresorbable vascular scaffolds in percutaneous coronary revascularization
N Azzi, W Shatila - Reviews in Cardiovascular Medicine, 2021 - imrpress.com
Coronary angioplasty was first introduced in 1977. From plain old balloon angioplasty to the
introduction of bare metal stents in 1986 and dual antiplatelet therapy in 1992 to much more …
introduction of bare metal stents in 1986 and dual antiplatelet therapy in 1992 to much more …
The therapeutic dilemma of recurrent in-stent restenosis
F Alfonso, J Cuesta - Circulation: Cardiovascular Interventions, 2018 - Am Heart Assoc
Circ Cardiovasc Interv. 2018; 11: e007109. DOI: 10.1161/CIRCINTERVENTIONS.
118.007109 August 2018 2 stent thrombosis, and target lesion revascularization. The 1-year …
118.007109 August 2018 2 stent thrombosis, and target lesion revascularization. The 1-year …